LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5.24 Cr | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5.24 Cr |
| Mar2025 | ₹1.90 Cr |
| Mar2024 | ₹1.77 Cr |
| Mar2023 | ₹8.95 Cr |
| Mar2022 | ₹79 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.24 Cr | 176.09 | |
| Mar2025 | ₹1.90 Cr | 7.11 | |
| Mar2024 | ₹1.77 Cr | -80.20 | |
| Mar2023 | ₹8.95 Cr | -88.70 | |
| Mar2022 | ₹79 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹265.8 Cr | 4% | 13.1% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 4% |
13.1% |
-25.5% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses